Table 3.

Prevalence of various albuminuria classes and corresponding incidence of RRT in the general as well as in high-risk populations^a

UAC (mg/L)	n	%	RRT (n)	IR
General population	40,854		45
<10	30,888	75.6	15	0.1
10 to 20	6766	16.6	4	0.1
20 to 100	2673	6.5	4	0.2
100 to 200	245	0.6	6	3.2
>200	282	0.7	16	8.0
CVD history	1475		8
<10	996	67.5	1	0.1
10 to 20	229	15.5	0	0.0
20 to 100	175	11.9	2	1.6
100 to 200	33	2.2	2	9.8
>200	42	2.8	3	12.2
No CVD history	39,379		37
<10	29,892	75.9	14	0.1
10 to 20	6537	16.6	4	0.1
20 to 100	2498	6.3	2	0.1
100 to 200	212	0.5	4	2.4
>200	240	0.6	13	7.4
With known hypertension/diabetes	5083		31
<10	3484	68.5	9	0.3
10 to 20	831	16.3	2	0.3
20 to 100	565	11.1	3	0.7
100 to 200	82	1.6	3	5.1
>200	121	2.4	14	18.1
Without known hypertension/diabetes	35,771		14
<10	27,404	76.6	6	0.0
10 to 20	5935	16.6	2	0.0
20 to 100	2108	5.9	1	0.1
100 to 200	163	0.5	3	2.3
>200	161	0.5	2	1.6
Age >55	13,616		33
<10	10,133	74.4	12	0.1
10 to 20	1969	14.5	1	0.1
20 to 100	1206	8.9	4	0.4
100 to 200	138	1.0	4	4.1
>200	170	1.2	12	10.9
Age ≤55	27,238		12
<10	20,755	76.2	3	0.0
10 to 20	4797	17.6	3	0.1
20 to 100	1467	5.4	0	0.0
100 to 200	107	0.4	2	2.2
>200	112	0.4	4	4.4
At least one of above risk factors	15,257		39
<10	11,284	74.0	13	0.1
10 to 20	2251	14.8	2	0.1
20 to 100	1369	9.0	4	0.4
100 to 200	156	1.0	5	4.5
>200	197	1.3	15	11.7
No risk factors	25,597		6
<10	19,604	76.6	2	0.0
10 to 20	4515	17.6	2	0.1
20 to 100	1304	5.1	0	0.0
100 to 200	89	0.3	1	1.3
>200	85	0.3	1	1.4

^aIR, incidence rate (events per 1000 person-years).